CCR5: no longer a 'good for nothing' gene - chemokine control of West Nile virus infection

被引：76

作者：

Lim, Jean K.

Glass, William G.

McDermott, David H.

Murphy, Philip M. ^{[1
]}

机构：

[1] NIAID, Lab Mol Immunol, Mol Signaling Sect, NIH, Bethesda, MD 20892 USA

[2] Centocor Global R&D, Infect Dis, Radnor, PA 19087 USA

来源：

TRENDS IN IMMUNOLOGY | 2006年 / 27卷 / 07期

关键词：

D O I：

10.1016/j.it.2006.05.007

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The chemokine receptor CCR5 was identified in 1996 as a crucial host factor exploited by HIV for cell entry. CCR5 presumably functions normally in antimicrobial host defense because it generally mediates leukocyte chemotactic responses; however, evidence of antimicrobial functions for CCR5 in humans has been elusive. Recently, genetic analyses in mice and humans have provided strong evidence for the CCR5 control of infection by West Nile virus (WNV), a re-emerging pathogen capable of causing fatal encephalitis. Thus, the same receptor can benefit or harm the host, depending on the virus. Although CCR5 might be a logical target for new drug development in HIV/AIDS, the benefits of blocking CCR5 could carry the cost of an increased risk of WNV disease in co-infected patients.

引用

页码：308 / 312

页数：5

共 53 条

[1] Role of G-protein-coupled signaling in the induction and regulation of dendritic cell function by Toxoplasma gondii [J].